Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
1299.61x
As of Nov 29, 2022
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Nov 29, 2022 | 1299.61x |
| Nov 28, 2022 | 1270.73x |
| Nov 25, 2022 | 1292.39x |
| Nov 23, 2022 | 1299.61x |
| Nov 22, 2022 | 1288.42x |
| Nov 21, 2022 | 1335.71x |
| Nov 18, 2022 | 1375.42x |
| Nov 17, 2022 | 1359.90x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison